# Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level

> **NCT03211403** · PHASE1 · COMPLETED · sponsor: **Atridia Pty Ltd.** · enrollment: 24 (actual)

## Conditions studied

- Gout
- Hyperuricemia

## Interventions

- **DRUG:** SHR4640

## Key facts

- **NCT ID:** NCT03211403
- **Lead sponsor:** Atridia Pty Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-04
- **Primary completion:** 2018-02-15
- **Final completion:** 2018-02-15
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2018-03-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03211403

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03211403, "Multiple Doses Study of SHR4640 in Male Subjects With High Serum Uric Acid Level". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03211403. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*